ArticleNeoplasia (New York, N.Y.)2017

Nilotinib Enhances Tumor Angiogenesis and Counteracts VEGFR2 Blockade in an Orthotopic Breast Cancer Xenograft Model with Desmoplastic Response.

Sara Zafarnia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.